APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aneurysmal Subarachnoid Hemorrhage Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Analysis and Forecast 2026-2032

Report ID 173963550219 December 2025198 pages

Choose your research edition.

Industry ResearchAneurysmal Subarachnoid Hemorrhage Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Aneurysmal Subarachnoid Hemorrhage Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Aneurysmal Subarachnoid Hemorrhage Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aneurysmal Subarachnoid Hemorrhage Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Aneurysmal Subarachnoid Hemorrhage Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Aneurysmal Subarachnoid Hemorrhage Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Aneurysmal Subarachnoid Hemorrhage Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Aneurysmal Subarachnoid Hemorrhage Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Aneurysmal Subarachnoid Hemorrhage Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Aneurysmal Subarachnoid Hemorrhage Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Aneurysmal Subarachnoid Hemorrhage Drugs include Arbor Pharmaceuticals, Orexo AB, PDS Biotechnology Corporation, Pharmaxis, Purdue Pharma, Pfizer, Mylan N.V, Johnson and Johnson and Sun Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Aneurysmal Subarachnoid Hemorrhage Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aneurysmal Subarachnoid Hemorrhage Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Aneurysmal Subarachnoid Hemorrhage Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aneurysmal Subarachnoid Hemorrhage Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aneurysmal Subarachnoid Hemorrhage Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aneurysmal Subarachnoid Hemorrhage Drugs sales, projected growth trends, production technology, application and end-user industry.

Aneurysmal Subarachnoid Hemorrhage Drugs Segment by Company

Arbor Pharmaceuticals

Orexo AB

PDS Biotechnology Corporation

Pharmaxis

Purdue Pharma

Pfizer

Mylan N.V

Johnson and Johnson

Sun Pharmaceutical Industries

Teva Pharmaceutical

Aneurysmal Subarachnoid Hemorrhage Drugs Segment by Type

Osmotic Agent

Anticonvulsant

Calcium Channel Blocker

Stool Softener

Opioid Analgesic

Other Drugs

Aneurysmal Subarachnoid Hemorrhage Drugs Segment by Application

Hospital

Clinic

Others

Aneurysmal Subarachnoid Hemorrhage Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aneurysmal Subarachnoid Hemorrhage Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aneurysmal Subarachnoid Hemorrhage Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aneurysmal Subarachnoid Hemorrhage Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Aneurysmal Subarachnoid Hemorrhage Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aneurysmal Subarachnoid Hemorrhage Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Osmotic Agent Major Manufacturers Table 3. Anticonvulsant Major Manufacturers Table 4. Calcium Channel Blocker Major Manufacturers Table 5. Stool Softener Major Manufacturers Table 6. Opioid Analgesic Major Manufacturers Table 7. Other Drugs Major Manufacturers Table 8. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Manufacturers Table 10. Clinic Major Manufacturers Table 11. Others Major Manufacturers Table 12. Aneurysmal Subarachnoid Hemorrhage Drugs Industry Trends Table 13. Aneurysmal Subarachnoid Hemorrhage Drugs Industry Drivers Table 14. Aneurysmal Subarachnoid Hemorrhage Drugs Industry Opportunities and Challenges Table 15. Aneurysmal Subarachnoid Hemorrhage Drugs Industry Restraints Table 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2021-2026) Table 20. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2027-2032) Table 21. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 22. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2021-2026) & (Tons) Table 23. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2027-2032) & (Tons) Table 24. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2021-2026) Table 25. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2027-2032) Table 26. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturers (2021-2026) Table 30. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 31. Global Aneurysmal Subarachnoid Hemorrhage Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Aneurysmal Subarachnoid Hemorrhage Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers, Product Type & Application Table 34. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Aneurysmal Subarachnoid Hemorrhage Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2021-2026) Table 41. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2027-2032) Table 42. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 43. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2026) & (Tons) Table 44. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2027-2032) & (Tons) Table 45. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2021-2026) Table 46. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2027-2032) Table 47. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2021-2026) & (US$/Ton) Table 48. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2027-2032) & (US$/Ton) Table 49. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2021-2026) Table 53. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2027-2032) Table 54. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 55. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2026) & (Tons) Table 56. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2027-2032) & (Tons) Table 57. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2021-2026) Table 58. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2027-2032) Table 59. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2021-2026) & (US$/Ton) Table 60. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2027-2032) & (US$/Ton) Table 61. Arbor Pharmaceuticals Company Information Table 62. Arbor Pharmaceuticals Business Overview Table 63. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 65. Arbor Pharmaceuticals Recent Development Table 66. Orexo AB Company Information Table 67. Orexo AB Business Overview Table 68. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 70. Orexo AB Recent Development Table 71. PDS Biotechnology Corporation Company Information Table 72. PDS Biotechnology Corporation Business Overview Table 73. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 75. PDS Biotechnology Corporation Recent Development Table 76. Pharmaxis Company Information Table 77. Pharmaxis Business Overview Table 78. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 80. Pharmaxis Recent Development Table 81. Purdue Pharma Company Information Table 82. Purdue Pharma Business Overview Table 83. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 85. Purdue Pharma Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 90. Pfizer Recent Development Table 91. Mylan N.V Company Information Table 92. Mylan N.V Business Overview Table 93. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 95. Mylan N.V Recent Development Table 96. Johnson and Johnson Company Information Table 97. Johnson and Johnson Business Overview Table 98. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 100. Johnson and Johnson Recent Development Table 101. Sun Pharmaceutical Industries Company Information Table 102. Sun Pharmaceutical Industries Business Overview Table 103. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 105. Sun Pharmaceutical Industries Recent Development Table 106. Teva Pharmaceutical Company Information Table 107. Teva Pharmaceutical Business Overview Table 108. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio Table 110. Teva Pharmaceutical Recent Development Table 111. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2026) & (Tons) Table 114. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2027-2032) & (Tons) Table 115. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 116. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 117. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2026) & (Tons) Table 120. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2027-2032) & (Tons) Table 121. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 122. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 123. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 127. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021-2026) & (Tons) Table 128. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2027-2032) & (Tons) Table 129. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 130. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 131. United States Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 132. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 133. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2026) & (Tons) Table 136. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2027-2032) & (Tons) Table 137. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 138. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 139. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2026) & (Tons) Table 142. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2027-2032) & (Tons) Table 143. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 144. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 145. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 149. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021-2026) & (Tons) Table 150. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2027-2032) & (Tons) Table 151. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 152. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 153. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 154. France Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 155. U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 156. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 158. Nordic Countries Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 159. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2026) & (US$ Million) Table 160. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2027-2032) & (US$ Million) Table 161. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2026) & (Tons) Table 162. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2027-2032) & (Tons) Table 163. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 164. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 165. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2026) & (US$ Million) Table 166. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2027-2032) & (US$ Million) Table 167. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2026) & (Tons) Table 168. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2027-2032) & (Tons) Table 169. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 170. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 171. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2026) & (Tons) Table 174. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2027-2032) & (Tons) Table 175. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 176. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 177. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2026) & (Tons) Table 180. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2027-2032) & (Tons) Table 181. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 182. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 183. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 187. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021-2026) & (Tons) Table 188. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2027-2032) & (Tons) Table 189. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 190. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 191. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 192. South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 193. India Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 194. Australia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2026) & (Tons) Table 200. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2027-2032) & (Tons) Table 201. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 202. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 203. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2026) & (Tons) Table 206. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2027-2032) & (Tons) Table 207. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 208. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 209. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 213. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021-2026) & (Tons) Table 214. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2027-2032) & (Tons) Table 215. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 216. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 217. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 218. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 219. Chile Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 220. Colombia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 221. Peru Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 223. Israel Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 224. UAE Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 225. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 226. Iran Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 227. Egypt Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Aneurysmal Subarachnoid Hemorrhage Drugs Distributors List Table 231. Aneurysmal Subarachnoid Hemorrhage Drugs Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Aneurysmal Subarachnoid Hemorrhage Drugs Image Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Osmotic Agent Image Figure 5. Anticonvulsant Image Figure 6. Calcium Channel Blocker Image Figure 7. Stool Softener Image Figure 8. Opioid Analgesic Image Figure 9. Other Drugs Image Figure 10. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2021-2032) & (US$ Million) Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2021-2032) Figure 20. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (2021-2032) & (Tons) Figure 21. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 22. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Sales YoY (2021-2032) & (Tons) Figure 24. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales YoY (2021-2032) & (Tons) Figure 25. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales YoY (2021-2032) & (Tons) Figure 26. Asia (Excluding China) Aneurysmal Subarachnoid Hemorrhage Drugs Sales YoY (2021-2032) & (Tons) Figure 27. South America, Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales YoY (2021-2032) & (Tons) Figure 28. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2021-2032) Figure 34. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 35. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2021-2032) Figure 37. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2021-2032) Figure 40. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 41. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2021-2032) Figure 43. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2021-2032) Figure 44. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2021-2032) Figure 45. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2021-2032) Figure 46. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2021-2032) Figure 47. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Country (2021-2032) Figure 48. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Country (2021-2032) Figure 49. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2021-2032) Figure 50. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2021-2032) Figure 51. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2021-2032) Figure 52. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2021-2032) Figure 53. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Country (2021-2032) Figure 54. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Country (2021-2032) Figure 55. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2021-2032) Figure 56. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2021-2032) Figure 57. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2021-2032) Figure 58. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2021-2032) Figure 59. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2021-2032) Figure 60. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2021-2032) Figure 61. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2021-2032) Figure 62. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2021-2032) Figure 63. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Country (2021-2032) Figure 64. Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Country (2021-2032) Figure 65. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2021-2032) Figure 66. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2021-2032) Figure 67. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2021-2032) Figure 68. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2021-2032) Figure 69. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Country (2021-2032) Figure 70. SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Country (2021-2032) Figure 71. Aneurysmal Subarachnoid Hemorrhage Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Aneurysmal Subarachnoid Hemorrhage Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Osmotic Agent
  • Anticonvulsant
  • Calcium Channel Blocker
  • Stool Softener
  • Opioid Analgesic
  • Other Drugs
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Arbor Pharmaceuticals
  • Orexo AB
  • PDS Biotechnology Corporation
  • Pharmaxis
  • Purdue Pharma
  • Pfizer
  • Mylan N.V
  • Johnson and Johnson
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market by Type
  3. 1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Osmotic Agent
  5. 1.2.3 Anticonvulsant
  6. 1.2.4 Calcium Channel Blocker
  7. 1.2.5 Stool Softener
  8. 1.2.6 Opioid Analgesic
  9. 1.2.7 Other Drugs
  10. 1.3 Aneurysmal Subarachnoid Hemorrhage Drugs Market by Application
  11. 1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Dynamics
  1. 2.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Trends
  2. 2.2 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Drivers
  3. 2.3 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Opportunities and Challenges
  4. 2.4 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region
  3. 3.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region
  9. 3.4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers
  2. 4.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturers
  6. 4.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Aneurysmal Subarachnoid Hemorrhage Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market CR5 and HHI
  16. 4.8.2 2025 Aneurysmal Subarachnoid Hemorrhage Drugs Tier 1, Tier 2, and Tier 3
5 Aneurysmal Subarachnoid Hemorrhage Drugs Market by Type
  1. 5.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type
  2. 5.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type
  6. 5.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type
6 Aneurysmal Subarachnoid Hemorrhage Drugs Market by Application
  1. 6.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application
  2. 6.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application
  6. 6.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application
7 Company Profiles
  1. 7.1 Arbor Pharmaceuticals
  2. 7.1.1 Arbor Pharmaceuticals Company Information
  3. 7.1.2 Arbor Pharmaceuticals Business Overview
  4. 7.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  6. 7.1.5 Arbor Pharmaceuticals Recent Developments
  7. 7.2 Orexo AB
  8. 7.2.1 Orexo AB Company Information
  9. 7.2.2 Orexo AB Business Overview
  10. 7.2.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  12. 7.2.5 Orexo AB Recent Developments
  13. 7.3 PDS Biotechnology Corporation
  14. 7.3.1 PDS Biotechnology Corporation Company Information
  15. 7.3.2 PDS Biotechnology Corporation Business Overview
  16. 7.3.3 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  18. 7.3.5 PDS Biotechnology Corporation Recent Developments
  19. 7.4 Pharmaxis
  20. 7.4.1 Pharmaxis Company Information
  21. 7.4.2 Pharmaxis Business Overview
  22. 7.4.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  24. 7.4.5 Pharmaxis Recent Developments
  25. 7.5 Purdue Pharma
  26. 7.5.1 Purdue Pharma Company Information
  27. 7.5.2 Purdue Pharma Business Overview
  28. 7.5.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  30. 7.5.5 Purdue Pharma Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Mylan N.V
  38. 7.7.1 Mylan N.V Company Information
  39. 7.7.2 Mylan N.V Business Overview
  40. 7.7.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  42. 7.7.5 Mylan N.V Recent Developments
  43. 7.8 Johnson and Johnson
  44. 7.8.1 Johnson and Johnson Company Information
  45. 7.8.2 Johnson and Johnson Business Overview
  46. 7.8.3 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  48. 7.8.5 Johnson and Johnson Recent Developments
  49. 7.9 Sun Pharmaceutical Industries
  50. 7.9.1 Sun Pharmaceutical Industries Company Information
  51. 7.9.2 Sun Pharmaceutical Industries Business Overview
  52. 7.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  54. 7.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 7.10 Teva Pharmaceutical
  56. 7.10.1 Teva Pharmaceutical Company Information
  57. 7.10.2 Teva Pharmaceutical Business Overview
  58. 7.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product Portfolio
  60. 7.10.5 Teva Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type
  2. 8.1.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2021-2032)
  5. 8.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
  6. 8.2.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2021-2032)
  9. 8.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country
  10. 8.3.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type
  2. 9.1.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2021-2032)
  5. 9.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
  6. 9.2.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2021-2032)
  9. 9.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country
  10. 9.3.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type
  2. 10.1.1 China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2021-2032)
  5. 10.2 China Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
  6. 10.2.1 China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type
  2. 11.1.1 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2021-2032)
  5. 11.2 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
  6. 11.2.1 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2021-2032)
  9. 11.3 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country
  10. 11.3.1 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Aneurysmal Subarachnoid Hemorrhage Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type
  2. 12.1.1 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
  6. 12.2.1 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Country
  10. 12.3.1 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Aneurysmal Subarachnoid Hemorrhage Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Aneurysmal Subarachnoid Hemorrhage Drugs Value Chain Analysis
  2. 13.1.1 Aneurysmal Subarachnoid Hemorrhage Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Aneurysmal Subarachnoid Hemorrhage Drugs Production Mode & Process
  6. 13.2 Aneurysmal Subarachnoid Hemorrhage Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Aneurysmal Subarachnoid Hemorrhage Drugs Distributors
  9. 13.2.3 Aneurysmal Subarachnoid Hemorrhage Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst